Table: Mochida Pharm -2022/23 parent results
May 15 (Reuters)-
Mochida Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 95.49 102.44
(-6.8 pct) (+7.5 pct)
Operating 6.41 11.37
(-43.6 pct) (+23.1 pct)
Recurring 8.97 13.54
(-33.7 pct) (+16.5 pct)
Net 7.25 10.44
(-30.6 pct) (+16.2 pct)
EPS 195.10 yen 274.03 yen
Ann Div 80.00 yen 90.00 yen 80.00 yen
-Q2 Div 40.00 yen 40.00 yen 40.00 yen
-Q4 Div 40.00 yen 50.00 yen 40.00 yen
NOTE - Mochida Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T